Vitura Health Limited (ASX:VIT)
Australia · Delayed Price · Currency is AUD 0.0250
0.00 (0.00%)
Aug 21, 2026, 1:14 PM AEST
Vitura Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 129.24 | 124.04 | 123.87 | 117.34 | 66.99 | 21.71 |
| 129.24 | 124.04 | 123.87 | 117.34 | 66.99 | 21.71 | |
Revenue Growth | 2.11% | 0.13% | 5.56% | 75.16% | 208.54% | 17431.02% |
Cost of Revenue | 96.91 | 90.29 | 89.65 | 77.65 | 41.56 | 15.06 |
Gross Profit | 32.32 | 33.75 | 34.22 | 39.69 | 25.43 | 6.66 |
Selling, General & Admin | 29.94 | 28.51 | 29.35 | 19.83 | 15.51 | 4.96 |
Operating Expenses | 29.94 | 28.51 | 29.35 | 19.83 | 15.51 | 4.96 |
Operating Income | 2.38 | 5.24 | 4.87 | 19.86 | 9.92 | 1.7 |
Interest Expense | -1.05 | -1.08 | -0.65 | -0.03 | -0.06 | -0.03 |
Interest & Investment Income | 0.32 | 0.43 | 0.67 | 0.33 | 0.01 | 0 |
Currency Exchange Gain (Loss) | -0.05 | 0.08 | -0.18 | -0.06 | -0.2 | - |
Other Non Operating Income (Expenses) | -0.04 | -0.03 | -0.15 | -0.06 | -0.15 | 0.13 |
EBT Excluding Unusual Items | 1.55 | 4.65 | 4.56 | 20.04 | 9.52 | 1.8 |
Gain (Loss) on Sale of Investments | -0.02 | 0.04 | - | 0.01 | - | - |
Gain (Loss) on Sale of Assets | 0.02 | 0.02 | 0 | 0.01 | 0.22 | - |
Other Unusual Items | - | - | - | - | - | 0.08 |
Pretax Income | 1.54 | 4.71 | 4.56 | 20.05 | 9.74 | 1.89 |
Income Tax Expense | 1.04 | 1.64 | 1.31 | 6.3 | 3.73 | 0.47 |
Earnings From Continuing Operations | 0.5 | 3.06 | 3.25 | 13.75 | 6.01 | 1.42 |
Minority Interest in Earnings | 0.29 | 0.26 | 0.26 | 0.06 | 0.04 | - |
Net Income | 0.78 | 3.32 | 3.51 | 13.81 | 6.05 | 1.42 |
Net Income to Common | 0.78 | 3.32 | 3.51 | 13.81 | 6.05 | 1.42 |
Net Income Growth | -59.69% | -5.35% | -74.56% | 128.31% | 326.72% | - |
Shares Outstanding (Basic) | 653 | 610 | 570 | 555 | 482 | 402 |
Shares Outstanding (Diluted) | 653 | 610 | 570 | 572 | 487 | 402 |
Shares Change | 13.19% | 7.01% | -0.33% | 17.44% | 21.21% | 337.86% |
EPS (Basic) | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 | 0.00 |
EPS (Diluted) | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 | 0.00 |
EPS Growth | -63.75% | -11.55% | -74.54% | 95.15% | 254.39% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | 1.38 | 2.58 | 6.67 | 8.78 | 13.14 | 0.89 |
Free Cash Flow Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | 0.00 |
Dividend Per Share | 0.002 | 0.002 | - | 0.010 | 0.010 | - |
Dividend Growth | - | - | - | 0% | - | - |
Gross Margin | 25.01% | 27.21% | 27.63% | 33.82% | 37.96% | 30.65% |
Operating Margin | 1.84% | 4.23% | 3.93% | 16.93% | 14.81% | 7.83% |
Profit Margin | 0.61% | 2.68% | 2.84% | 11.77% | 9.03% | 6.53% |
Free Cash Flow Margin | 1.07% | 2.08% | 5.38% | 7.48% | 19.61% | 4.11% |
EBITDA | 1.93 | 5.64 | 5.78 | 20.22 | 10.12 | 1.78 |
EBITDA Margin | 1.49% | 4.55% | 4.67% | 17.23% | 15.11% | 8.21% |
D&A For EBITDA | -0.45 | 0.4 | 0.91 | 0.36 | 0.2 | 0.08 |
EBIT | 2.38 | 5.24 | 4.87 | 19.86 | 9.92 | 1.7 |
EBIT Margin | 1.84% | 4.23% | 3.93% | 16.93% | 14.81% | 7.83% |
Effective Tax Rate | 67.78% | 34.93% | 28.79% | 31.44% | 38.30% | 24.91% |